Aastrom Set To Start Pivotal Work On Stem Cell Therapy May 9, 2007 By Aaron Lorenzo No Comments Aastrom Biosciences Inc. received FDA clearance to begin a pivotal trial of its regenerative stem cell product in osteonecrosis of the femoral head. (BioWorld Today)Read More
Varying FOB Proposals Seem To Signal Compromise In The Works May 3, 2007 By Aaron Lorenzo No Comments